Evaluasi Kepatuhan Penggunaan Obat Anti Tuberkulosis Pada Pasien TBC Anak Di Klinik Ananda Siaga Kecamatan Cianjur Periode Januari-September Tahun 2024: Evaluation of Compliance with the Use of Anti-Tuberculosis Drugs in Pediatric Tuberculosis Patients at the Ananda Siaga Clinic, Cianjur Sub-District, January - September Period In 2024

Eneng Puspita Wati (Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Indonesia Maju, Jakarta Indonesia)
Imam Syafi'i (Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Indonesia Maju, Jakarta Indonesia)
Julia Totong (Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Indonesia Maju, Jakarta Indonesia)

Jurnal Ilmiah Farmasi Indonesia (JIFIN)
Vol 3 No 01 (2025): JIFIN : Jurnal Ilmiah Farmasi Indonesia Terbitan Juni 2025

Tuberculosis (TB) is an infectious disease that remains a major global health problem and the second leading cause of death after HIV/AIDS. It is caused by Mycobacterium tuberculosis. Children with TB are increasingly susceptible to infection as the number of adult TB cases continues to rise. This study aimed to evaluate adherence to anti-tuberculosis drug (OAT) use among children with TB at Ananda Siaga Clinic, Cianjur District. This research employed a non-experimental quantitative approach with a cross-sectional design. A total of 189 samples were obtained through purposive sampling from 360 patients during the period of January–September 2024. Adherence levels were measured using the Morisky Medication Adherence Scale (MMAS-8). The results showed that the accuracy of diagnosis, drug selection in both intensive and continuation phases, and frequency of OAT administration reached 100%. Dose accuracy was recorded at 75.13%. The treatment adherence level was high, with 82% of children being adherent. However, there was no significant relationship between adherence level and drug use (p = 0.094). In conclusion, TB treatment in children at Ananda Siaga Clinic was in accordance with the 2016 National Tuberculosis Control Guidelines.